Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 1
2004 1
2005 1
2006 3
2007 3
2009 1
2010 2
2011 3
2012 5
2013 4
2014 2
2015 4
2016 5
2017 8
2018 4
2019 5
2020 10
2021 13
2022 12
2023 8
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.
Reijers ILM, Menzies AM, van Akkooi ACJ, Versluis JM, van den Heuvel NMJ, Saw RPM, Pennington TE, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Rozeman EA, Klop WMC, van Houdt WJ, Sikorska K, van der Hage JA, Grünhagen DJ, Wouters MW, Witkamp AJ, Zuur CL, Lijnsvelt JM, Torres Acosta A, Grijpink-Ongering LG, Gonzalez M, Jóźwiak K, Bierman C, Shannon KF, Ch'ng S, Colebatch AJ, Spillane AJ, Haanen JBAG, Rawson RV, van de Wiel BA, van de Poll-Franse LV, Scolyer RA, Boekhout AH, Long GV, Blank CU. Reijers ILM, et al. Among authors: van der hage ja. Nat Med. 2022 Jun;28(6):1178-1188. doi: 10.1038/s41591-022-01851-x. Epub 2022 Jun 5. Nat Med. 2022. PMID: 35661157 Clinical Trial.
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Lansu J, et al. Among authors: van der hage ja. JAMA Oncol. 2021 Jan 1;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. JAMA Oncol. 2021. PMID: 33180100 Free PMC article. Clinical Trial.
Where Robotic Surgery Meets the Metaverse.
van Leeuwen FWB, van der Hage JA. van Leeuwen FWB, et al. Among authors: van der hage ja. Cancers (Basel). 2022 Dec 14;14(24):6161. doi: 10.3390/cancers14246161. Cancers (Basel). 2022. PMID: 36551645 Free PMC article.
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.
van den Berg JH, Heemskerk B, van Rooij N, Gomez-Eerland R, Michels S, van Zon M, de Boer R, Bakker NAM, Jorritsma-Smit A, van Buuren MM, Kvistborg P, Spits H, Schotte R, Mallo H, Karger M, van der Hage JA, Wouters MWJM, Pronk LM, Geukes Foppen MH, Blank CU, Beijnen JH, Nuijen B, Schumacher TN, Haanen JBAG. van den Berg JH, et al. Among authors: van der hage ja. J Immunother Cancer. 2020 Aug;8(2):e000848. doi: 10.1136/jitc-2020-000848. J Immunother Cancer. 2020. PMID: 32753545 Free PMC article. Clinical Trial.
Neoadjuvant chemotherapy for operable breast cancer.
Mieog JS, van der Hage JA, van de Velde CJ. Mieog JS, et al. Among authors: van der hage ja. Br J Surg. 2007 Oct;94(10):1189-200. doi: 10.1002/bjs.5894. Br J Surg. 2007. PMID: 17701939 Review.
Quality indicators in breast cancer care.
Del Turco MR, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, Decker T, Dietel M, Gentilini O, Kuehn T, Mano MP, Mantellini P, Marotti L, Poortmans P, Rank F, Roe H, Scaffidi E, van der Hage JA, Viale G, Wells C, Welnicka-Jaskiewicz M, Wengstöm Y, Cataliotti L. Del Turco MR, et al. Among authors: van der hage ja. Eur J Cancer. 2010 Sep;46(13):2344-56. doi: 10.1016/j.ejca.2010.06.119. Epub 2010 Jul 31. Eur J Cancer. 2010. PMID: 20675120
Personalising sarcoma care using quantitative multimodality imaging for response assessment.
Kalisvaart GM, Bloem JL, Bovée JVMG, van de Sande MAJ, Gelderblom H, van der Hage JA, Hartgrink HH, Krol ADG, de Geus-Oei LF, Grootjans W. Kalisvaart GM, et al. Among authors: van der hage ja. Clin Radiol. 2021 Apr;76(4):313.e1-313.e13. doi: 10.1016/j.crad.2020.12.009. Epub 2021 Jan 19. Clin Radiol. 2021. PMID: 33483087 Free article. Review.
The management of soft tissue tumours of the abdominal wall.
Smith HG, Tzanis D, Messiou C, Benson C, van der Hage JA, Fiore M, Bonvalot S, Hayes AJ. Smith HG, et al. Among authors: van der hage ja. Eur J Surg Oncol. 2017 Sep;43(9):1647-1655. doi: 10.1016/j.ejso.2017.04.009. Epub 2017 May 6. Eur J Surg Oncol. 2017. PMID: 28528910 Review.
Quality indicators in breast cancer care: An update from the EUSOMA working group.
Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kühn T, Mansel RE, Ponti A, Poortmans P, Regitnig P, van der Hage JA, Wengström Y, Rosselli Del Turco M. Biganzoli L, et al. Among authors: van der hage ja. Eur J Cancer. 2017 Nov;86:59-81. doi: 10.1016/j.ejca.2017.08.017. Epub 2017 Sep 28. Eur J Cancer. 2017. PMID: 28963914 Review.
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
de Wild SR, van Roozendaal LM, de Wilt JHW, van Dalen T, van der Hage JA, van Duijnhoven FH, Simons JM, Schipper RJ, de Munck L, van Kuijk SMJ, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, van de Vijver KKBT, de Vries J, Westenberg AH, Strobbe LJA, Smidt ML. de Wild SR, et al. Among authors: van der hage ja. Br J Surg. 2024 Apr 3;111(4):znae077. doi: 10.1093/bjs/znae077. Br J Surg. 2024. PMID: 38597154 Free PMC article.
88 results